← FDA Drug Approvals (Drugs@FDA)

NDA209628

NDA · New Drug Application · Sponsor: CIPLA USA · Approved 2024-12-20

Drug application

FDA Application #

NDA209628

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

CIPLA USA

First approval

2024-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown